Skip to content
Governance Register

← US public companies

Schwab Andrew J.

SEC-identified person · CIK 1598549 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Camp4 Therapeutics Corp CAMP Director filed 2024 - 2026
Skye Bioscience, Inc. SKYE Director filed 2023 - 2026
Entrada Therapeutics, Inc. TRDA Officer filed 2021 - 2025
Artiva Biotherapeutics, Inc. ARTV Officer filed 2024 - 2024
Imara Inc. IMRA Director filed 2023 - 2024
Thimble Point Acquisition Corp. THMAU Director filed 2021 - 2023
Rallybio Corp RLYB Officer filed 2021 - 2023
Cincor Pharma, Inc. CINC Officer filed 2022 - 2023
Akouos, Inc. AKUS Officer filed 2020 - 2022
Scpharmaceuticals Inc. SCPH Officer filed 2017 - 2022
Vor Biopharma Inc. VOR Officer filed 2021 - 2021
Cabaletta Bio, Inc. CABA Officer filed 2019 - 2021
IPI Legacy Liquidation Co IMPLQ Officer filed 2021 - 2021
Q32 Bio Inc. QTTB Officer filed 2018 - 2020
5:01 Acquisition Corp. FVAM Director · Co-CEO filed 2020 - 2020
Ideaya Biosciences, Inc. IDYA Officer filed 2019 - 2020
Aprea Therapeutics, Inc. APRE Officer filed 2019 - 2020
Arvinas, INC. AVRN Officer filed 2018 - 2019
Crinetics Pharmaceuticals, Inc. CRNX Officer filed 2018 - 2019
Audentes Therapeutics, Inc. BOLD Officer filed 2016 - 2017
Phaserx, INC. PZRX Officer filed 2016 - 2016
Viveve Medical, INC. plcsf Officer filed 2014 - 2015
Cidara Therapeutics, Inc. CDTX Officer filed 2015 - 2015
Zalicus Inc. ZLCS Officer filed 2014 - 2015
Flexion Therapeutics Inc FLXN Director filed 2014 - 2014

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.